TABLE 1.
Antimicrobial susceptibility of G. adiacens, G. elegans, and A. defectiva
| Antimicrobial agent and species (no. of isolates) | MIC (μg/ml) |
Interpretive breakpoint (μg/ml)a or % of isolates |
||||
|---|---|---|---|---|---|---|
| Range | MIC50 | MIC90 | Susceptible | Intermediate | Resistant | |
| Penicillin | ≤0.12 | 0.25–2 | ≥4 | |||
| G. adiacens (426) | ≤0.03 to ≥16 | 0.25 | 2 | 39.4b | 50.7b | 9.9 |
| G. elegans (20) | ≤0.03–8 | ≤0.03 | 0.25 | 80c | 15c | 5 |
| A. defectiva (152) | ≤0.03–8 | 0.5 | 8 | 13.8d | 63.2d | 23d |
| Ceftriaxone | ≤1 | 2 | ≥4 | |||
| G. adiacens (426) | ≤0.06 to ≥32 | 2 | ≥16 | 47.2b | 24.4 | 28.4b |
| G. elegans (20) | ≤0.06 to ≥16 | 0.12 | 1 | 90 | 5 | 5 |
| A. defectiva (151) | 0.12 to ≥16 | 0.5 | 1 | 98d | 1.3d | 0.7d |
| Erythromycin | ≤0.25 | 0.5 | ≥1 | |||
| G. adiacens (413) | ≤0.12 to ≥8 | ≥8 | ≥8 | 44.6 | 0.2 | 55.2 |
| G. elegans (19) | ≤0.12 to ≥8 | ≤0.12 | ≥8 | 52.6 | 47.4 | |
| A. defectiva (143) | ≤0.12 to ≥8 | ≥8 | ≥8 | 39.9 | 0.7 | 59.4 |
| Clindamycin | ≤0.25 | 0.5 | ≥1 | |||
| G. adiacens (414) | ≤0.03 to ≥32 | 0.06 | ≥4 | 77.3 | 2.9 | 19.8 |
| G. elegans (19) | ≤0.03 to ≥4 | 0.12 | 0.5 | 89.4 | 5.3 | 5.3 |
| A. defectiva (143) | ≤0.03–4 | 0.12 | 0.25 | 92.3d | 5.6 | 2.1d |
| Meropenem | ≤0.5 | 1 | ≥2 | |||
| G. adiacens (425) | ≤0.06 to ≥16 | 0.12 | 0.5 | 91.3 | 6.4 | 2.4 |
| G. elegans (20) | ≤0.06–1 | ≤0.06 | 0.25 | 95 | 5 | |
| A. defectiva (150) | 0.12–2 | 0.5 | 1 | 80.7d | 18.7d | 0.6 |
| Levofloxacin | ≤2 | 4 | ≥8 | |||
| G. adiacens (414) | ≤0.25 to ≥16 | 1 | 2 | 91.6 | 0.7 | 7.7 |
| G. elegans (19) | ≤0.25–1 | 0.5 | 1 | 100 | ||
| A. defectiva (144) | 0.25–4 | ≤0.25 | 0.5 | 99.3d | 0.7 | 0d |
| Vancomycin | ≤1 | |||||
| G. adiacens (423) | ≤0.5–1 | 1 | 1 | 100 | ||
| G. elegans (20) | ≤0.5–1 | 1 | 1 | 100 | ||
| A. defectiva (152) | ≤0.5–1 | 0.5 | 1 | 100 | ||
| Daptomycin | ||||||
| G. adiacens (343) | ≤0.25 to ≥8 | 4 | ≥8 | |||
| G. elegans (19) | ≤0.25 to ≥8 | 0.5 | 2 | |||
| A. defectiva (119) | ≤0.25–4 | 2 | 4 | |||
| Linezolid | ||||||
| G. adiacens (413) | ≤0.25–2 | 1 | 1 | |||
| G. elegans (19) | 0.5–1 | 0.5 | 1 | |||
| A. defectiva (143) | ≤0.25–2 | 1 | 1 | |||
| Gentamicin | ||||||
| G. adiacens (414) | ≤0.12 to ≥16 | 2 | 4 | |||
| G. elegans (19) | 0.25–2 | 1 | 2 | |||
| A. defectiva (143) | ≤0.12 to ≥16 | 2 | 4 | |||
| TMP/SMX | ||||||
| G. adiacens (391) | ≤0.12/2.4 to ≥8/152 | 0.25/4.8 | 4/76 | |||
| G. elegans (18) | 0.25/4.8–4/76 | 0.25/4.8 | 4/76 | |||
| A. defectiva (128) | ≤0.12/2.4 to ≥4/76 | 0.25/4.8 | 0.25/4.8 | |||
| Doxycycline | ||||||
| G. adiacens (410) | ≤0.06 to ≥16 | ≤0.12 | 8 | |||
| G. elegans (19) | ≤0.12–8 | ≤0.12 | 8 | |||
| A. defectiva (144) | ≤0.06–8 | ≤0.12 | 2 | |||
| Rifampin | ||||||
| G. adiacens (387) | ≤0.5 to ≥8 | ≤0.5 | ≤0.5 | |||
| G. elegans (18) | ≤0.5 | ≤0.5 | ≤0.5 | |||
| A. defectiva (126) | ≤0.5–1 | ≤0.5 | ≤0.5 | |||
Interpretive breakpoints are shown in bold for each antibiotic.
P value shows significant differences (P < 0.05) between G. adiacens and G. elegans.
P value shows significant differences (P < 0.05) between G. elegans and A. defectiva.
P value shows significant differences (P < 0.05) between A. defectiva and G. adiacens.